Platelets and osteoblasts: secretome connections

Am J Physiol Cell Physiol. 2022 Aug 1;323(2):C347-C353. doi: 10.1152/ajpcell.00187.2022. Epub 2022 Jun 8.

Abstract

Megakaryocyte hyperplasia associated with myeloproliferative neoplasms commonly leads to abnormal bone tissue deposition in the bone marrow, known as osteosclerosis. In this study, we aimed to synthesize the known proteomics literature describing factors released by megakaryocytes and platelets and to examine if any of the secreted factors have a known ability to stimulate the bone-forming cells, osteoblasts. Using a systematic search of Medline, we identified 77 articles reporting on factors secreted by platelets and megakaryocytes. After a full-text screening and analysis of the studies, we selected seven papers that reported proteomics data for factors secreted by platelets from healthy individuals. From 60 proteins reported in at least two studies, we focused on 23 that contained a putative signal peptide, which we searched for a potential osteoblast-stimulatory function. From nine proteins with a positive effect on osteoblast formation and function, two extracellular matrix (ECM) proteins, secreted protein acidic and rich in cysteine (SPARC) and tissue inhibitor of metalloproteinase-1 (TIMP1), and three cellular proteins with known extracellular function, the 70-kDa heat shock protein (HSP70), thymosin-β4 (TB4), and super dismutase (SOD), were identified as hypothetical candidate molecules to be examined as potential mediators in mouse models of osteomyelofibrosis. Thus, careful analysis of prior literature can be beneficial in assisting the planning of future experimental studies.

Keywords: myelofibrosis; osteoblast; osteosclerosis; platelet; secretome.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Platelets* / metabolism
  • Extracellular Matrix Proteins / metabolism
  • Mice
  • Osteoblasts / metabolism
  • Osteonectin* / metabolism
  • Secretome
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism

Substances

  • Extracellular Matrix Proteins
  • Osteonectin
  • Tissue Inhibitor of Metalloproteinase-1

Grants and funding